Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MYTX-011 by Mythic Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
MYTX-011 is under clinical development by Mythic Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Data Insights
MYTX-011 by Mythic Therapeutics for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
MYTX-011 is under clinical development by Mythic Therapeutics and currently in Phase I for Squamous Non-Small Cell Lung Cancer. According...